Gyroscope Capital Management Group, LLC Eli Lilly & CO Put Options Transaction History

Gyroscope Capital Management Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Jul 16, 2020	SELL	$136.42 - $164.18 $190,987 - $229,852	-1,400 Closed	0 $0
Q1 2020 Apr 13, 2020	SELL	$119.05 - $147.35 $23,810 - $29,470	-200 Reduced 12.5%	1,400 $3,000
Q4 2019 Jan 29, 2020	BUY	$106.92 - $132.43 $171,072 - $211,888	1,600 New	1,600 $0
Q1 2019 Apr 22, 2019	SELL	$111.31 - $131.02 $17.8 Million - $21 Million	-160,000 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $16.7 Million - $18.7 Million	158,000 Added 7900.0%	160,000 $0
Q1 2018 May 21, 2018	BUY	$74.21 - $87.6 $148,420 - $175,200	2,000 New	2,000 $0

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Gyroscope Capital Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Gyroscope Capital Management Group, LLC with notifications on news.